#32: Building a FemTech, don’t look too passionate about it - Fatoumata Ly
Many businesses start with the future founders trying to solve an issue they face personally. FemTech startups (female technology) are no exception. Here, however, many areas are emotionally loaded and wrapped into layers of taboos. Fatoumata Ly shares how her own story of trying to conceive evolved into addressing the centuries-old issue countless women face. Fatoumata is now building Ninti, a company that provides digital solutions for personalised care around sexual and reproductive health. Topics we discuss:Raising awareness around reproductive health and breaking taboos in the workplace. Are employers ready? And employees?How to convert horrible customer stories about pain, loss or trauma into a company vision and a product, and keep building despite own heartbreaking circumstancesHow much vulnerability and authenticity a founder can affordHow can passion be treated differently based on who is displaying it. Is it a strength or a weakness?Does everyone have the luxury to just… be? About Fatoumata Ly (guest): Fatoumata Ly is a Franco-Guinean entrepreneur, currently a co-founder of Ninti, a company that provides digital solutions for personalised care around sexual and reproductive health. She is also a member of the board of directors of SISTA, a French NGO that focuses on reducing the funding gap between male and female entrepreneurs. Fatoumata is committed to putting women at the centre of the healthcare and entrepreneurship system. She actively works to reduce gender inequalities in the areas of reproductive health and entrepreneurship, with a soft spot for emerging markets. About Darya Kamkalova (host): Darya is a data industry professional, a startup mentor, and a speaker. She is committed to narrowing the gender investment gap for female founders and diverse teams. Darya is based in Berlin, Germany. Venturing Women website: https://www.venturingwomen.org/ Follow us on social media: Instagram - LinkedIn
From "Venturing Women"
Comments
Add comment Feedback